📋 Tender Overview
The AOK Bayern intends to enter into non-exclusive discount agreements for the active ingredient Nevirapin, ATC J05AG01, with all interested pharmaceutical companies. This is not an open procedure but an open-house model, allowing contracts to be concluded at any time during the contract period, which starts on November 1, 2026, and ends on October 31, 2028. Interested pharmaceutical companies must demonstrate their suitability through a completed and signed declaration of reliability. Nevirapin, ATC J05AG01
